title: Bcl2 phosphorylation and active PKC alpha are associated with poor survival in AML.
authors.forename: S
authors.initials: S
authors.lastname: Kurinna
authors.forename: M
authors.initials: M
authors.lastname: Konopleva
authors.forename: S L
authors.initials: SL
authors.lastname: Palla
authors.forename: W
authors.initials: W
authors.lastname: Chen
authors.forename: S
authors.initials: S
authors.lastname: Kornblau
authors.forename: R
authors.initials: R
authors.lastname: Contractor
authors.forename: X
authors.initials: X
authors.lastname: Deng
authors.forename: W S
authors.initials: WS
authors.lastname: May
authors.forename: M
authors.initials: M
authors.lastname: Andreeff
authors.forename: P P
authors.initials: PP
authors.lastname: Ruvolo
mesh_terms: D000208:Acute Disease; D006801:Humans; D007951:Leukemia, Myeloid / Q000378:metabolism* / Q000401:mortality*; D010766:Phosphorylation; D051571:Protein Kinase C-alpha / Q000378:metabolism*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism*; D015996:Survival Rate
chemical_list: D019253:Proto-Oncogene Proteins c-bcl-2; D051571:Protein Kinase C-alpha